BRIEF

on Viromed Medical AG (isin : DE000A3MQR65)

Viromed Medical AG Begins Production of ViroCAP® for HELLMUT RUCK GmbH

Viromed Medical AG has commenced production of the ViroCAP® OEM version for HELLMUT RUCK GmbH. This partnership, first announced in November 2025, has now reached a pivotal milestone with the start of production. HELLMUT RUCK GmbH will market the ViroCAP® exclusively in podiatry across Europe, the UK, and Switzerland. This initiative opens access to a vast customer base of over 120,000.

Viromed's collaboration with RUCK highlights their strategic approach to growth in the medical technology sector, particularly in the podiatry market. Additionally, Viromed is preparing further international sales collaborations, with a focus on regions such as the UAE, Qatar, Saudi Arabia, and Kuwait.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Viromed Medical AG news